Past Events

History of previous events

Apitope to Present at Bio€quity Europe in May 2016

Cardiff, UK and Hasselt, Belgium: 9 May 2016 − Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announces that Dr Keith Martin, CEO of Apitope, is scheduled to present at Bio€quity Europe on Tuesday, 10 May 2016 at 2.20 pm CET at the Scandic Hotel, Copenhagen,…


9th Annual Congress of the European Association for haemophilia and allied disorders (EAHAD)- 3rd—5th February 2016, Malmo, Sweden

Apitope’s research director, Lotta Jansson will be presenting at the EAHAD conference. For further information please see:


JP Morgan Annual Healthcare Conference – 11th-14th January 2016, San Francisco

Apitope’s commercial director & general counsel will be attending the JP Morgan conference in San Francisco during 11th-14th January 2016. Please contact Hayley.french@apitope for further information.


Genesis Conference – 10th December 2015, London

Apitope will be attending the Genesis conference in London on the 10th December 2015 and CEO, Keith Martin will be speaking on the panel session “international growth strategies in Europe”. For further information please see:


Immunotherapy@Brisbane – November 24th – 26th 2015 – Brisbane, Australia

Prof. David Wraith, Apitope’s founder and CSO, will be speaking at the Immunotherapy@Brisbane conference, held November 24th –26th at the Brisbane convention and Exhibition Centre, in Brisbane, Australia. David will be giving a presentation during the fifth session on autoimmune disease on November 25th from 9:20AM onwards. For more details about the conference, please visit…


BioPharm America™ – September 15th – 17th 2015 – Boston, USA

Our commercial director and general counsel, Dr. Hayley French will be attending the 8th annual edition of BioPharm America™, held September 15th – 17th in Boston, USA. Hayley will be taking part in the partnering sessions and is looking forward to meeting with you to discuss potential partnerships. For further information, please visit the conference…